Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanoma

Author(s):
Pors, L.J. (0000-0003-0907-6637); Marinkovic, M.; Deuzeman, H.H.; Vu, T.H.K.; Kerkhof, E.M.; Wieringen-Warmenhoven, K.M. van; Rasch, C.R.N. (0000-0001-6950-3376); Bleeker, J.C.; Koetsier, L.S.; Beenakker, J.W.M. (0000-0003-0479-5587); Luyten, G.P.M.; Creutzberg, C.L. (0000-0002-7008-4321); Horeweg, N. (0000-0002-8581-4753)
Published
2025
Publication type
Article / Letter to editor
Uveal melanomaBrachytherapyVisual acuityNeoplasm recurrenceLocal
Date issued
2025-05-31
Language
English
Publisher
Elsevier
Is part of
Clinical and Translational Radiation Oncology
hdl
1887/4288987
doi
10.1016/j.ctro.2025.100939